- Home
- ACAD vs FBK Comparison
ACAD vs FBK Comparison
Compare ACAD & FBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACAD
- FBK
- Stock Information
- Founded
- ACAD 1993
- FBK 1906
- Country
- ACAD United States
- FBK United States
- Employees
- ACAD N/A
- FBK N/A
- Industry
- ACAD Biotechnology: Pharmaceutical Preparations
- FBK Major Banks
- Sector
- ACAD Health Care
- FBK Finance
- Exchange
- ACAD Nasdaq
- FBK Nasdaq
- Market Cap
- ACAD 2.8B
- FBK 2.6B
- IPO Year
- ACAD 2004
- FBK 2016
- Fundamental
- Price
- ACAD $17.57
- FBK $52.39
- Analyst Decision
- ACAD Buy
- FBK Hold
- Analyst Count
- ACAD 19
- FBK 6
- Target Price
- ACAD $26.17
- FBK $48.67
- AVG Volume (30 Days)
- ACAD 4.3M
- FBK 169.2K
- Earning Date
- ACAD 02-25-2025
- FBK 01-21-2025
- Dividend Yield
- ACAD N/A
- FBK 1.30%
- EPS Growth
- ACAD N/A
- FBK N/A
- EPS
- ACAD 0.78
- FBK 2.30
- Revenue
- ACAD $929,236,000.00
- FBK $436,397,000.00
- Revenue This Year
- ACAD $36.78
- FBK N/A
- Revenue Next Year
- ACAD $8.19
- FBK $10.45
- P/E Ratio
- ACAD $22.63
- FBK $22.80
- Revenue Growth
- ACAD 47.06
- FBK N/A
- 52 Week Low
- ACAD $14.15
- FBK $33.35
- 52 Week High
- ACAD $29.29
- FBK $58.88
- Technical
- Relative Strength Index (RSI)
- ACAD 52.06
- FBK 51.41
- Support Level
- ACAD $16.61
- FBK $51.54
- Resistance Level
- ACAD $18.23
- FBK $53.31
- Average True Range (ATR)
- ACAD 0.74
- FBK 1.38
- MACD
- ACAD -0.05
- FBK 0.24
- Stochastic Oscillator
- ACAD 36.59
- FBK 82.77
About ACAD ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
About FBK FB Financial Corporation
FB Financial Corp is a bank holding company. The company through its wholly-owned bank subsidiary provides commercial and consumer banking services to clients in select markets in Tennessee, North Alabama, and North Georgia. The company segment includes Banking and Mortgage. It generates revenue from the Banking segment which provides a full range of deposit and lending products and services to corporate, commercial, and consumer customers. The Mortgage segment includes the servicing of residential mortgage loans and the packaging and securitization of loans to governmental agencies.